My Intelligent Machines
My Intelligent Machines helps biopharma teams run accurate biological simulations to improve early-stage drug development and patient stratification. The company offers an augmented intelligence, explainable AI SaaS platform that combines systems biology models, computer modeling, distributed computing, and federated learning to integrate and analyze molecular and clinical data. Its software supports selection of therapeutic targets, biomarkers, and patient subgroups for personalized therapies. The platform is marketed to life-science and biopharma customers and is delivered as enterprise-facing B2B SaaS from its Montreal base.
My Intelligent Machines
My Intelligent Machines helps biopharma teams run accurate biological simulations to improve early-stage drug development and patient stratification. The company offers an augmented intelligence, explainable AI SaaS platform that combines systems biology models, computer modeling, distributed computing, and federated learning to integrate and analyze molecular and clinical data. Its software supports selection of therapeutic targets, biomarkers, and patient subgroups for personalized therapies. The platform is marketed to life-science and biopharma customers and is delivered as enterprise-facing B2B SaaS from its Montreal base.